4.6 Article

Association of rare variants in neurodegenerative genes with familial Alzheimer's disease

Journal

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
Volume 7, Issue 10, Pages 1985-1995

Publisher

WILEY
DOI: 10.1002/acn3.51197

Keywords

-

Funding

  1. National Natural Science Foundation of China [81671075, 81971029, 81701134]
  2. National Key R&D Program of China [2017YFC0840100, 2017YFC0840104]
  3. Provincial Key Plan for Research and Development of Hunan [2017SK2031]
  4. Provincial Technology Innovation Guidance Plan Project of Hunan [2108SK52601]
  5. Youth Program of Science Foundation of Xiangya Hospital [2018Q017]

Ask authors/readers for more resources

Objective: To investigate the impact of rare variants underlying neurodegenerative-related genes to familial Alzheimer's disease (AD). Methods: We performed targeted sequencing of 277 neurodegenerative-related genes on probands from 75 Chinese AD families non-carrying causative mutation of dementia genes. Rare coding variants segregated in families were tested for association in an independent cohort of 506 patients with sporadic AD and 498 cognitively normal controls. East Asians data from the Exome Aggregation Consortium (ExAC) were used as a reference control. Results: A novel rare variant, P410S ofPLD3was found in an early-onset AD family.LRRK2I2012T, a causative mutation of Parkinson's disease, was identified in another early-onset AD family. Missense variants inABCA7(P143S and A1507T) andCR1(T239M) were significantly associated with familial AD (P = 0.005437, 0.001383, 0.000549), a missense variant inTREM2(S183C) was significantly associated with AD (P = 0.000396) when compared with the East Asian controls in ExAC database. A non-frameshift variant in FUS (G223del) was frequent in AD cases and significantly associated with familial AD (P = 0.008). Interpretation: Multiple rare coding variants of causal and risk neurodegenerative genes were presented in clinically diagnosed AD families that may confer risk of AD. Our data supported that the clinical, pathological, and genetic architectures of AD, PD, and FTD/ALS may overlapping. We propose that targeted sequencing on neurodegenerative-related genes is necessary for genetically unclear AD families.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available